Delivery Order SPE2DB22D1017-SPE2DB25FYPBY
- Not listed
- The Defense Logistics Agency awarded a $5,882.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Januvia 50 mg tablets (90-count packages). The contract, with an ultimate completion date of July 23, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026. This...
- The Defense Logistics Agency awarded a $5,078.66 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Januvia 100 mg tablets (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,641.20 to AmerisourceBergen Drug Corp for the supply of Januvia 50 mg tablets (90-count units) under a firm fixed price contract type. The award was issued on July 21, 2025, with an ultimate completion date of July 22, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $32,255.09 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count units) under a firm fixed price contract type. The award was issued on July 31, 2025, with an ultimate completion date of August 1, 2025, and represents a non-competitive set-aside delivery order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Januvia 100 mg tablets (90-count packages) under a firm fixed-price contract with a ceiling value of $3.9K. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1B global pharmaceutical support vehicle running through December 2026. The award was made through open...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,182.92 to AmerisourceBergen Drug Corp for the supply of Januvia 50 mg tablets (90-count) under a firm fixed-price contract type. The contract was competitively awarded with no set-aside designation and carries an ultimate completion date of August 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,091.46 to AmerisourceBergen Drug Corp for the supply of Januvia 50 mg tablets (90-count) on August 14, 2025, with completion targeted for August 15, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a $3,416.79 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Januvia 100 mg tablets (90-count units). This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with performance at the contractor's Conshohocken, Pennsylvania location and an ultimate completion date of July 24, 2025. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,401.81 on July 22, 2025, for the supply of Januvia 100 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 23, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,683.24 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Januvia 100 mg tablets (90-count) under a firm fixed-price contract. The order, which has an ultimate completion date of July 25, 2025, will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively procured with no set-aside designation and operates as a child contract under a larger vehicle. This...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYPBYDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,637.19 to AmerisourceBergen Drug Corp for the supply of Januvia 50 mg tablets (90-count package) on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $1 billion through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a substantial portfolio of federal contracts with the DLA Medical Supply Chain covering a broad spectrum of pharmaceutical products and medical supplies. The parent company's extensive experience fulfilling federal medical procurement requirements through open competition, combined with its capacity to supply critical medications across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positions it as a key vendor within the military pharmaceutical supply ecosystem. Januvia, a diabetes medication, represents one of many pharmaceutical products the company delivers to support federal healthcare operations through its prime vendor arrangement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/25/25 |